Galsulfase IV 1mg/ml Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for IV
Available Strengths: 1mg/ml
Originator reference: - (brand names belong to their owners and are shown only to identify the originator medicine)
Category: Orphan Drugs
Galsulfase is an enzyme replacement therapy that provides the deficient N-acetylgalactosamine-6-sulfatase enzyme in Morquio A syndrome. It reduces the buildup of glycosaminoglycans in the body, improving mobility, breathing, and overall functioning, leading to enhanced quality of life in affected patients.
Manufacture or export Galsulfase IV? List it or send an offer →
Product Description: Galsulfase, marketed as Vimizim®, is approved in the US and EU for mucopolysaccharidosis type IVA (Morquio A syndrome). Regulatory dossiers include comprehensive clinical trial data, manufacturing practices, and safety profiles submitted to FDA and EMA, supporting its approval. Dossiers demonstrate its efficacy in reducing symptoms and improving mobility. Administered via IV infusion, dosing is individualized according to patient weight.
Galsulfase IV — third party manufacturing & bulk supply
Galsulfase IV 1mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Galsulfase IV is supplied as Lyophilized powder for IV — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Galsulfase IV listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Galsulfase IV →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Related Products
Alglucosidase Alfa IV
Strength:
50 mg/vial
Form: Lyophilized powder
Originator reference: Lumizyme®(US & EU)
View DetailsNitisinone Tablets
Strength:
2 mg and 5 mg
Form: Tablets
Originator reference: Orfadin®
View DetailsTreprostinil IV
Strength:
2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)
Form: SC or Intravenous (IV)
Originator reference: Remodulin(US & EU)
View DetailsIloprost Inahalation Solution
Strength:
10 mcg/mL
Form: Inhalation Solution (Nebulizer)
Originator reference: Ventavis®(EU & US)
View DetailsPalovarotene
Strength:
5 mg, 10 mg
Form: Capsules
Originator reference: Sohonos (USA/EU)
View DetailsNavepegritide Injection
Strength:
1.3 mg, 2.8 mg, 5.5 mg
Form: Powder vial for subcutaneous injection
Originator reference: Yuviwel
View DetailsPegzilarginase Injection
Strength:
5 mg/mL (2 mg/0.4 mL vial)
Form: Solution vial (IV or subcutaneous)
Originator reference: Loargys
View DetailsCopper Histidinate Injection
Strength:
250 mcg copper (as copper histidinate) per dose
Form: Subcutaneous injection
Originator reference: Zycubo
View DetailsUsually answered within 48 hours | GMP documents shared before you commit